These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 36245288)

  • 1. Rational determination of cefazolin dosage regimen in horses based on pharmacokinetics/pharmacodynamics principles and Monte Carlo simulations.
    Kuroda T; Minamijima Y; Mita H; Tamura N; Fukuda K; Kuwano A; Toutain PL; Sato F
    J Vet Pharmacol Ther; 2023 Jan; 46(1):62-67. PubMed ID: 36245288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rational dosage regimens for cephalothin and cefazolin using pharmacokinetics and pharmacodynamics analysis in healthy horses.
    Kuroda T; Minamijima Y; Niwa H; Tamura N; Mita H; Fukuda K; Kaimachi M; Suzuki Y; Enoki Y; Taguchi K; Matsumoto K; Toutain PL; Bousquet-Melou A; Kasashima Y
    Equine Vet J; 2021 Nov; 53(6):1239-1249. PubMed ID: 33341979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics/pharmacodynamics cut-off determination for fosfomycin using Monte Carlo simulation in healthy horses.
    Kuroda T; Minamijima Y; Niwa H; Mita H; Tamura N; Fukuda K; Toutain PL; Ohta M
    J Vet Med Sci; 2024 Apr; 86(4):413-420. PubMed ID: 38346727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic/pharmacodynamic analysis of cephalothin after intramuscular administration in Thoroughbred horses.
    Kuroda T; Minamijima Y; Niwa H; Mita H; Tamura N; Fukuda K; Ohta M
    J Equine Sci; 2023 Dec; 34(4):111-114. PubMed ID: 38274556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medication control of flunixin in racing horses: Possible detection times using Monte Carlo simulations.
    Kuroda T; Minamijima Y; Nomura M; Yamashita S; Yamada M; Nagata S; Mita H; Tamura N; Fukuda K; Kuwano A; Kusano K; Toutain PL; Sato F
    Equine Vet J; 2022 Sep; 54(5):979-988. PubMed ID: 34719043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population pharmacokinetics and pharmacokinetic/pharmacodynamic evaluation of marbofloxacin against Coagulase-negative staphylococci, Staphylococcus aureus and Mycoplasma agalactiae pathogens in goats.
    Serrano-Rodríguez JM; Fernández-Varón E; Rodríguez CMC; Andrés-Larrea MIS; Rubio-Langre S; de la Fe C; Dova SW; Bhardwaj P; Sidhu PK; Litterio NJ; Lorenzutti AM
    Res Vet Sci; 2023 Jun; 159():1-10. PubMed ID: 37060837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics, milk penetration and PK/PD analysis by Monte Carlo simulation of marbofloxacin, after intravenous and intramuscular administration to lactating goats.
    Lorenzutti AM; Litterio NJ; Himelfarb MA; Zarazaga MDP; San Andrés MI; De Lucas JJ
    J Vet Pharmacol Ther; 2017 Dec; 40(6):629-640. PubMed ID: 28470723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of tobramycin following intravenous, intramuscular, and intra-articular administration in healthy horses.
    Newman JC; Prange T; Jennings S; Barlow BM; Davis JL
    J Vet Pharmacol Ther; 2013 Dec; 36(6):532-41. PubMed ID: 23531033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population pharmacokinetics and pharmacodynamics of cefazolin using total and unbound serum concentrations in patients with high body weight.
    Chung EK; Cheatham SC; Healy DP; Stock AH; Utley S; Campion M; Murrey T; Gesenhues AM; Jeffery J; Kays MB
    Int J Antimicrob Agents; 2023 Apr; 61(4):106751. PubMed ID: 36758780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic-pharmacodynamic cutoff values for benzylpenicillin in horses to support the establishment of clinical breakpoints for benzylpenicillin antimicrobial susceptibility testing in horses.
    Lallemand EA; Bousquet-Mélou A; Chapuis L; Davis J; Ferran AA; Kukanich B; Kuroda T; Lacroix MZ; Minamijima Y; Olsén L; Pelligand L; Portugal FR; Roques BB; Santschi EM; Wilson KE; Toutain PL
    Front Microbiol; 2023; 14():1282949. PubMed ID: 37954237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temocillin dosing in haemodialysis patients based on population pharmacokinetics of total and unbound concentrations and Monte Carlo simulations.
    Miranda Bastos AC; Vandecasteele SJ; Spinewine A; Tulkens PM; Van Bambeke F
    J Antimicrob Chemother; 2018 Jun; 73(6):1630-1638. PubMed ID: 29579214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and oral bioavailability of cannabidiol in horses after intravenous and oral administration with oil and micellar formulations.
    Sánchez de Medina A; Serrano-Rodríguez JM; Díez de Castro E; García-Valverde MT; Saitua A; Becero M; Muñoz A; Ferreiro-Vera C; Sánchez de Medina V
    Equine Vet J; 2023 Nov; 55(6):1094-1103. PubMed ID: 36624043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tolerability and Pharmacokinetics of Contezolid at Therapeutic and Supratherapeutic Doses in Healthy Chinese Subjects, and Assessment of Contezolid Dosing Regimens Based on Pharmacokinetic/Pharmacodynamic Analysis.
    Wu J; Wu H; Wang Y; Chen Y; Guo B; Cao G; Wu X; Yu J; Wu J; Zhu D; Guo Y; Yuan H; Hu F; Zhang J
    Clin Ther; 2019 Jun; 41(6):1164-1174.e4. PubMed ID: 31126694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma and target-site subcutaneous tissue population pharmacokinetics and dosing simulations of cefazolin in post-trauma critically ill patients.
    Roberts JA; Udy AA; Jarrett P; Wallis SC; Hope WW; Sharma R; Kirkpatrick CM; Kruger PS; Roberts MS; Lipman J
    J Antimicrob Chemother; 2015 May; 70(5):1495-502. PubMed ID: 25608584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and Pharmacodynamics of Levornidazole in Patients With Intra-abdominal AnaerobicInfection.
    Wu H; Xie S; Yu J; Chen Y; Wu J; Guo B; Zhu Z; Zhou Y; Wang Z; Zhang J
    Clin Ther; 2018 Sep; 40(9):1548-1555. PubMed ID: 30146271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of plasma concentration after intravenous and intramuscular penicillin administration over 24 hr in healthy adult horses.
    Younkin JT; Santschi EM; Kukanich B; Lubbers BV; Warner M
    J Vet Pharmacol Ther; 2019 Mar; 42(2):239-242. PubMed ID: 30387161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and bioavailability of cefazolin in horses.
    Sams RA; Ruoff WW
    Am J Vet Res; 1985 Feb; 46(2):348-52. PubMed ID: 3994100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic evaluation of marbofloxacin after intravenous administration at different ages in llama crias, and pharmacokinetic/pharmacodynamic analysis by Monte Carlo simulation.
    Rubio-Langre S; Aguilar-Sola S; Lorenzutti AM; San Andrés MI; De Lucas JJ; Litterio NJ
    J Vet Pharmacol Ther; 2018 Dec; 41(6):861-870. PubMed ID: 30020535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and pharmacodynamics of doxycycline in a Streptococcusequi subsp. zooepidemicus infection model in horses.
    Chapuis RJJ; Smith JS; Uehlinger FD; Meachem M; Johnson R; Dowling PM
    J Vet Pharmacol Ther; 2021 Sep; 44(5):766-775. PubMed ID: 34057219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population pharmacokinetics of cefazolin in critically ill children infected with methicillin-sensitive Staphylococcus aureus.
    Salvador E; Oualha M; Bille E; Beranger A; Moulin F; Benaboud S; Boujaafar S; Gana I; Urien S; Zheng Y; Toubiana J; Briand C; Bustarret O; Geslain G; Renolleau S; Treluyer JM; Hirt D
    Clin Microbiol Infect; 2021 Mar; 27(3):413-419. PubMed ID: 32360445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.